Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capillary blood vessels are the smallest blood vessels in living tissue, consisting of a single layer of endothelial cells. They are central to cutaneous and subcutaneous blood flow and are often the physical target in dermatological laser therapy. Photothermolysis refers to the selective destruction, closure, or permeability alteration of these vessels using appropriately chosen wavelengths, pulse durations, and fluence of laser energy. The principle relies on the higher absorption of laser energy by hemoglobin relative to surrounding tissue, resulting in localized heating, coagulation, and vessel wall damage, with clinical applications in treating vascular lesions like port wine stains, hemangiomas, telangiectasias, and spider veins. This is not a conventional molecular target, but a physical therapy concept exploiting tissue optics and thermodynamics for vascular intervention[4][5][6][7][8].
Selective photothermolysis: laser energy absorbed by hemoglobin in red blood cells heats and damages the capillary wall, causing coagulation, vessel closure, or increased permeability
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Capillary blood vessel.